Bacteriotherapy in Pediatric Inflammatory Bowel Disease
This trial is active, not recruiting.
|Conditions||inflammatory bowel disease, crohn's disease, ulcerative colitis, cd|
|Collaborator||Seattle Children's Hospital|
|Start date||December 2012|
|End date||October 2013|
|Trial size||20 participants|
|Trial identifier||NCT01757964, 14267|
In this study, the investigators want to see if Bacteriotherapy (also referred to as stool transplantation) improves the symptoms and decreases inflammation in children with Inflammatory Bowel Disease (IBD). Examples of IBD are Crohn's Disease and Ulcerative Colitis. Additionally, researchers want to learn whether this experimental therapy delays the need for starting additional medications to treat pediatric IBD.
|Endpoint classification||safety/efficacy study|
|Intervention model||single group assignment|
Study stool recipient's will receive approximately 30 grams of processed donor stool through a tube into their stomach for the transplant.
Response to Stool Transplantation
time frame: 12 weeks
Male or female participants from 12 years up to 21 years old.
Inclusion Criteria: - Children ages 12-21 years old with a diagnosis of mild to moderate Ulcerative Colitis or Crohn's Disease - Willing parent to donate stool for the transplant Exclusion Criteria: - Severe Disease - History of intra-abdominal abscess, intra-abdominal fistula or stricturing - History of other systemic diseases - The patient has received TNF inhibitors to treat their IBD within two months of transplant
|Official title||Bacteriotherapy in Pediatric Inflammatory Bowel Disease|
Call for more information